Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AdaptHealthAHCO -2.92%64 FCF Yield % is 12.94 as of Aug. 19, 2026, which is 39% above its 10-year median of 9.32. GuruFocus rates AHCO with a GF Score™ of 64/100 and a GF Value™ of $10.50 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 849 Medical Devices & Instruments companies, AdaptHealth ranks better than 95.52% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
AdaptHealth FCF Yield % Related Terms
AdaptHealth FCF Yield % Historical Data
* Premium members only.
The historical data trend for AdaptHealth's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, AdaptHealth's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AdaptHealth FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AdaptHealth's FCF Yield % distribution charts can be found below:
* The bar in red indicates where AdaptHealth's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AdaptHealth (AHCO) has a FCF Yield % of 12.94 as of Aug. 19, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on AdaptHealth and its competitors. This is 39% above median its historical median of 9.32. According to the industry distribution chart, AdaptHealth ranks #38 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 4.5%.
Is AdaptHealth's FCF Yield % too high?
AdaptHealth's current FCF Yield % of 12.94 is 39% above median its 10-year median of 9.32. Based on the distribution chart, AdaptHealth ranks #38 out of 849 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, AdaptHealth has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AdaptHealth's FCF Yield % compare to INSP and IART?
According to the Medical Devices & Instruments industry distribution chart, AdaptHealth ranks #38 out of 849 companies for FCF Yield %. This places AdaptHealth in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on AdaptHealth and its competitors. AdaptHealth's current FCF Yield % is 12.94, which is 39% above median its own 10-year median of 9.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AdaptHealth stock overvalued right now?
Based on GuruFocus' analysis, AdaptHealth (AHCO) is currently considered Possible Value Trap. The stock's GF Value™ is $10.50, compared to a current price of $5.66 — trading 46.1% below its estimated fair value. The current FCF Yield % is 12.94, which is 39% above median its 10-year median of 9.32. AdaptHealth's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For AdaptHealth (AHCO), the current FCF Yield % is 12.94 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AdaptHealth (AHCO) Overvalued in 2026?
Based on GuruFocus' analysis, AdaptHealth stock appears to be undervalued.
The current stock price of $5.66 is trading 46.1% below its estimated GF Value™ of $10.50.
GuruFocus considers AdaptHealth to be Possible Value Trap.
Key valuation signals for AHCO:
FCF Yield %: 12.94 (39% above median its 10-year median of 9.32)
GF Value™: $10.50 vs. price of $5.66 (46.1% below fair value)
No single metric tells the full story. See the AHCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
64GF Score
Get the complete analysis for AHCO
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AHCO has been successfully added to your 
